A Pilot Study of PLX3397 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastasis and High Circulating Tumor Cell (CTC) Counts
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2015
At a glance
- Drugs Pexidartinib (Primary)
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- Sponsors Plexxikon
- 10 Jun 2017 Biomarkers information updated
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.